Cited by 635Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 197 of the 200 references it cites were found in a registry or an index, and 3 are not checked yet.

Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis

Open access

Viola, Kirsten L., Klein, William L.·2015·Acta Neuropathologica

DOI 10.1007/s00401-015-1386-3PMC PMC4390393

Open this paper in CoChat — free account

Abstract

Protein aggregation is common to dozens of diseases including prionoses, diabetes, Parkinson's and Alzheimer's. Over the past 15 years, there has been a paradigm shift in understanding the structural basis for these proteinopathies. Precedent for this shift has come from investigation of soluble Aβ oligomers (AβOs), toxins now widely regarded as instigating neuron damage leading to Alzheimer's dementia. Toxic AβOs accumulate in AD brain and constitute long-lived alternatives to the disease-defining Aβ fibrils deposited in amyloid plaques. Key experiments using fibril-free AβO solutions demonstrated that while Aβ is essential for memory loss, the fibrillar Aβ in amyloid deposits is not the agent. The AD-like cellular pathologies induced by AβOs suggest their impact provides a unifying mechanism for AD pathogenesis, explaining why early stage disease is specific for memory and accounting for major facets of AD neuropathology. Alternative ideas for triggering mechanisms are being actively investigated. Some research favors insertion of AβOs into membrane, while other evidence supports ligand-like accumulation at particular synapses. Over a dozen candidate toxin receptors have been proposed. AβO binding triggers a redistribution of critical synaptic proteins and induces hyperactivity in metabotropic and ionotropic glutamate receptors. This leads to Ca(2+) overload and instigates major facets of AD neuropathology, including tau hyperphosphorylation, insulin resistance, oxidative stress, and synapse loss. Because different species of AβOs have been identified, a remaining question is which oligomer is the major pathogenic culprit. The possibility has been raised that more than one species plays a role. Despite some key unknowns, the clinical relevance of AβOs has been established, and new studies are beginning to point to co-morbidities such as diabetes and hypercholesterolemia as etiological factors. Because pathogenic AβOs appear early in the disease, they offer appealing targets for therapeutics and diagnostics. Promising therapeutic strategies include use of CNS insulin signaling enhancers to protect against the presence of toxins and elimination of the toxins through use of highly specific AβO antibodies. An AD-dependent accumulation of AβOs in CSF suggests their potential use as biomarkers and new AβO probes are opening the door to brain imaging. Overall, current evidence indicates that Aβ oligomers provide a substantive molecular basis for the cause, treatment and diagnosis of Alzheimer's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00401-015-1386-3

Cites

197 of 200 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
Retracted
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Self-citation
Journal of Biological Chemistry
Kurkinensp, M., CondongT, M. R., Blumberg, B., Barlow, D. P., Quiñones, S., Sausg, J., & Pihlajaniemisyy, T. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc · Cited by 3,427
Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962
High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856

Flagged first, then by citations

Show all 198 references

Research works printed but not linked: 1

Nigh AB, Vahedi S, Davis EG, Weintraub S, Bigio EH, Klein WL, Geula C (2014) Intracellular Amyloid-beta in cholinergic neurons. Brain J Neurol: In Press

Sorted by citations

Items 201–300 of 635

Current strategies of detecting Aβ species and inhibiting Aβ aggregation: Status and prospects
Li, J., Liao, W., Huang, D., Ou, M., Chen, T., Wang, X., Zhao, R., Zhang, L., Mei, L., Liu, J., et al. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215375 · Cited by 37
Molecular basis of selective amyloid‐β degrading enzymes in Alzheimer's disease
Żukowska, J., Moss, S. J., Subramanian, V., & Acharya, K. R. (2023) · FEBS Journal · doi:10.1111/febs.16939 · Cited by 36
MSC-Derived Extracellular Vesicles Alleviate NLRP3/GSDMD-Mediated Neuroinflammation in Mouse Model of Sporadic Alzheimer’s Disease
Lin, L., Huang, L., Huang, S., Chen, W., Huang, H., Li, C., Su, F., Liu, X., Yuan, K., Jiang, Q., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03914-1 · Cited by 36
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Nabizadeh, F., Seyedmirzaei, H., & Karami, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-66211-w · Cited by 36
Structural analysis of copper(I) interaction with amyloid β peptide
Gregorio, G. D., Biasotto, F., Hecel, A., Łuczkowski, M., Kozłowski, H., & Valensin, D. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.03.006 · Cited by 34
Age-Specific Retinal and Cerebral Immunodetection of Amyloid-β Plaques and Oligomers in a Rodent Model of Alzheimer’s Disease
Habiba, U., Merlin, S., Lim, J. K. H., Wong, V. H. Y., Nguyen, C. T. O., Morley, J. W., Bui, B. V., & Tayebi, M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191346 · Cited by 33
Stem cell in neurodegenerative disorders; an emerging strategy
Ahani‐Nahayati, M., Shariati, A., Mahmoodi, M., Zekiy, A. O., Javidi-Aghdam, K., Shamlou, S., Mousakhani, A., Zamani, M., & Hassanzadeh, A. (2021) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10101 · Cited by 34
Biphasic Alteration of the Inhibitory Synapse Scaffold Protein Gephyrin in Early and Late Stages of an Alzheimer Disease Model
Kiss, É., Gorgas, K., Schlicksupp, A., Groß, D., Kins, S., Kirsch, J., & Kuhse, J. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.05.013 · Cited by 34
CRISPR/Cas9 system and its applications in nervous system diseases
Jiang, H., Tang, M.-Y., Xu, Z., Wang, Y., Li, M., Zheng, S., Zhu, J., Lin, Z., & Zhang, M. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.03.017 · Cited by 41
Synaptic proteasome is inhibited in Alzheimer’s disease models and associates with memory impairment in mice
Ribeiro, F. C., Cozachenco, D., Heimfarth, L., Fortuna, J. T. S., de Freitas, G. B., de Sousa, J. M., Alves‐Leon, S. V., Leite, R. E. P., Suemoto, C. K., Grinberg, L. T., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05511-9 · Cited by 34
Emerging Trends: Neurofilament Biomarkers in Precision Neurology
Sharma, P., Giri, A., & Tripathi, P. N. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04244-3 · Cited by 33
Tyrosol Reduces Amyloid-β Oligomer Neurotoxicity and Alleviates Synaptic, Oxidative, and Cognitive Disturbances in Alzheimer’s Disease Model Mice
Taniguchi, K., Yamamoto, F., Arai, T., Yang, J., Sakai, Y., Itoh, M., Mamada, N., Sekiguchi, M., Yamada, D., Saitoh, A., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190098 · Cited by 34
Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer’s Disease
Ettcheto, M., Sánchez‐López, E., Gómez-Mínguez, Y., Cabrera, H., Busquets, O., Beas‐Zárate, C., García, M. L., Carro, E., Casadesús, G., Auladell, C., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0868-4 · Cited by 32
An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging
Wang, X., Kastanenka, K. V., Arbel‐Ornath, M., Commins, C., Kuzuya, A., Lariviere, A., Krafft, G. A., Hefti, F. F., Jerecı̀ć, J., & Bacskai, B. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22979-2 · Cited by 32
Free-floating adult human brain-derived slice cultures as a model to study the neuronal impact of Alzheimer’s disease-associated Aβ oligomers
Mendes, N. D., Fernandes, A., de Almeida, G. M., Santos, L. E., Sellés, M. C., Silva, N. M. L. E., Machado, C. D. M., Horta‐Júnior, J. D. A. C., Louzada, P. R., Felice, F. G. D., et al. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.05.021 · Cited by 35
Self-citation
Imaging sigma receptors in the brain: New opportunities for diagnosis of Alzheimer’s disease and therapeutic development
Jia, H., Zhang, Y., & Huang, Y. H. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.07.033 · Cited by 32
The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer's disease
Antonioni, A., Martorana, A., Santarnecchi, E., Hampel, H. J., & Koch, G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70337 · Cited by 31
Effects of safflower yellow on beta-amyloid deposition and activation of astrocytes in the brain of APP/PS1 transgenic mice
Shi, X., Zhang, H., Zhou, Z., Ruan, Y., Pang, J., Zhang, L., Zhai, W., & Hu, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.099 · Cited by 30
Aβ pathology downregulates brain mGluR5 density in a mouse model of Alzheimer
Lee, M., Lee, H., Park, I. S., Park, J. A., Kwon, Y., Ryu, Y. H., Kim, C. H., Kang, J. H., Hyun, I. Y., Lee, K. C., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.02.003 · Cited by 30
On the Common Journey of Neural Cells through Ischemic Brain Injury and Alzheimer’s Disease
Kriška, J., Heřmanová, Z., Knotek, T., Turečková, J., & Anděrová, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189689 · Cited by 33
Targeting glutamatergic and cellular prion protein mechanisms of amyloid β-mediated persistent synaptic plasticity disruption: Longitudinal studies
Zhang, D., Qi, Y., Klyubin, I. V., Ondrejčák, T., Sarell, C. J., Cuello, A. C., Collinge, J., & Rowan, M. J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.03.036 · Cited by 32
Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer’s Disease
Ettcheto, M., Abad, S., Petrov, D., Pedrós, I., Busquets, O., Sánchez‐López, E., Casadesús, G., Beas‐Zárate, C., Carro, E., Auladell, C., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0690-4 · Cited by 28
Rhodamine-Based Metal Chelator: A Potent Inhibitor of Metal-Catalyzed Amyloid Toxicity
Pradhan, K., Das, G., Kar, C., Mukherjee, N., Khan, J., Mahata, T., Barman, S., & Ghosh, S. (2020) · ACS Omega · doi:10.1021/acsomega.0c02235 · Cited by 30
The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer’s Disease
Xia, Q., Yang, X., Shi, J., Liu, Z., Peng, Y., Wang, W., Li, B., Zhao, Y., Xiao, J., Huang, L. F., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02385-y · Cited by 32
The Prophylactic and Multimodal Activity of Two Isatin Thiosemicarbazones against Alzheimer’s Disease In Vitro
Mavroidi, B., Kaminari, A., Matiadis, D., Hadjipavlou‐Litina, D., Pelecanou, M., Tzinia, A. K., & Sagnou, M. (2022) · Brain Sciences · doi:10.3390/brainsci12060806 · Cited by 30
c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases
Gutiérrez, D. A., Chandía-Cristi, A., Yañez, M. J., Zanlungo, S., & Alvarez, A. R. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.346540 · Cited by 31
Insight into the internal structure of amyloid-β oligomers by isotope-edited Fourier transform infrared spectroscopy
Baronio, C. M., Baldassarre, M., & Barth, A. (2019) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp00717b · Cited by 30
A metabolic perspective of late onset Alzheimer’s disease
Ettcheto, M., Cano, A. C., Busquets, O., Manzine, P. R., Sánchez‐López, E., Castro-Torres, R. D., Beas‐Zárate, C., Verdaguer, E., García, M. L., Olloquequi, J., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104255 · Cited by 31
Amylin in Alzheimer's disease: Pathological peptide or potential treatment?
Mietlicki‐Baase, E. G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.016 · Cited by 30
Galangin decreases p‑tau, Aβ42 and β‑secretase levels, and suppresses autophagy in okadaic acid‑induced PC12 cells via an Akt/GSK3β/mTOR signaling‑dependent mechanism
Huang, L., Lin, M., Zhong, X., Yang, H., & Deng, M. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9824 · Cited by 29
Phytohormone abscisic acid ameliorates cognitive impairments in streptozotocin-induced rat model of Alzheimer's disease through PPARβ/δ and PKA signaling
Khorasani, A., Abbasnejad, M., & Esmaeili‐Mahani, S. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1634067 · Cited by 29
Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease
Govindarajulu, M., Ramesh, S., Neel, L. T., Fabbrini, M., Buabeid, M. A., Fujihashi, A., Dwyer, D., Lynd, T. O., Shah, K., Mohanakumar, K. P., et al. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104958 · Cited by 31
Post-Translational Modifications of BACE1 in Alzheimer's Disease
Wen, W., Li, P., Liu, P., Xu, S., Wang, F., & Huang, J. H. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210121163224 · Cited by 33
The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer’s Disease
Viola, K. L., Bicca, M. A., Bebenek, A. M., Kranz, D. L., Nandwana, V., Waters, E. A., Haney, C. R., Lee, M. Y., Gupta, A., Brahmbhatt, Z., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.768646 · Cited by 29
Self-citation
Detection of Amyloid Beta (Aβ) Oligomeric Composition Using Matrix-Assisted Laser Desorption Ionization Mass Spectrometry (MALDI MS)
Wang, J. S.-H., Whitehead, S. N., & Yeung, K. K. ‐. (2018) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-018-1896-z · Cited by 31
Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer’s disease
Qian, Z., Wang, Z., Li, B., Meng, X., Kuang, Z., Li, Y., Yang, Y., & Ye, K. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02565-x · Cited by 28
Real-Time Analysis of Binding Events between Different Aβ1–42 Species and Human Lilrb2 by Dual Polarization Interferometry
Hu, T., Wang, S., Chen, C., Sun, J., & Yang, X. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04950 · Cited by 28
A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer’s disease
van Dyck, C. H., Mecca, A. P., O’Dell, R. S., Bartlett, H. H., Diepenbrock, N. G., Huang, Y., Hamby, M. E., Grundman, M., Catalano, S. M., Caggiano, A. O., et al. (2024) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01382-2 · Cited by 29
Alzheimer disease: Amyloid peptide controversies and challenges of anti-Aβ immunotherapy
Almohmadi, N. H., Al-Kuraishy, H. M., Albuhadily, A. K., Al-Gareeb, A. I., Abdelaziz, A. M., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103639 · Cited by 29
Sinensetin Attenuates Amyloid Beta25-35-Induced Oxidative Stress, Inflammation, and Apoptosis in SH-SY5Y Cells Through the TLR4/NF-κB Signaling Pathway
Zhi, Z., Tang, X., Wang, Y., Chen, R., & Ji, H. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03406-x · Cited by 29
Dimethyl Itaconate Reduces Cognitive Impairment and Neuroinflammation in APPswe/PS1ΔE9 Transgenic Mouse Model of Alzheimer’s Disease
Xiong, J., Lu, D., Chen, B.-Q., Liu, T., & Wang, Z. (2022) · NeuroMolecular Medicine · doi:10.1007/s12017-022-08725-y · Cited by 29
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter
LaBarbera, K. M., Sheline, Y. I., Izzo, N. J., Yuede, C. M., Waybright, L., Yurko, R., Edwards, H. M., Gardiner, W. D., Blennow, K., Zetterberg, H., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00358-w · Cited by 25
Neuroepigenetics of ageing and neurodegeneration-associated dementia: An updated review
Mir, F. A., Amanullah, A., Jain, B. P., Hyderi, Z., & Gautam, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102067 · Cited by 30
Clearance of amyloid β-protein and its role in the spreading of Alzheimer's disease pathology
Thal, D. R. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00025 · Cited by 28
Post-translational regulation of the β-secretase BACE1
Araki, W. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.009 · Cited by 26
Rosetta Stone for Amyloid Fibrils: The Key Role of Ring-Like Oligomers in Amyloidogenesis
Galzitskaya, O. V., & Selivanova, O. M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170230 · Cited by 28
Differential protective effects of connective tissue growth factor against Aβ neurotoxicity on neurons and glia
Yang, C.-N., Wu, M.-F., Liu, C.-C., Jung, W.-H., Chang, Y.-C., Lee, W.-P., Shiao, Y.-J., Wu, C.-L., Liou, H.-H., Lin, S.-K., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx278 · Cited by 27
Sulforaphane Reverses the Amyloid-β Oligomers Induced Depressive-Like Behavior
Wang, W., Wei, C., Quan, M., Li, T., & Jia, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200397 · Cited by 27
Accumulation of cellular prion protein within β‐amyloid oligomer plaques in aged human brains
Takahashi, R. H., Yokotsuka, M., Tobiume, M., Sato, Y., Hasegawa, H., Nagao, T., & Gouras, G. K. (2021) · Brain Pathology · doi:10.1111/bpa.12941 · Cited by 27
Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer’s Disease
Drummond, E., Goñi, F., Liu, S., Prelli, F., Scholtzova, H., & Wısnıewskı, T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179909 · Cited by 26
Chinese Herbal Medicine Xueshuantong Enhances Cerebral Blood Flow and Improves Neural Functions in Alzheimer’s Disease Mice
Huang, Y., Guo, B., Shi, B., Gao, Q., & Zhou, Q. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170763 · Cited by 26
Elucidating the inhibitory potential of Vitamin A against fibrillation and amyloid associated cytotoxicity
Alam, P., Siddiqi, M. K., Malik, S., Chaturvedi, S. K., Uddin, M., & Khan, R. H. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.01.134 · Cited by 26
β-Amyrin Ameliorates Alzheimer's Disease-Like Aberrant Synaptic Plasticity in the Mouse Hippocampus
Park, H. J., Kwon, H., Lee, J., Cho, E., Lee, Y. C., Moon, M., Jun, M., Kim, D. H., & Jung, J. W. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2019.024 · Cited by 27
Soluble Epoxide Hydrolase and Brain Cholesterol Metabolism
Domingues, M. F., Callai-Silva, N., Piovesan, A. R., & Carlini, C. R. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00325 · Cited by 26
Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity
Limegrover, C. S., LeVine, H., Izzo, N. J., Yurko, R., Mozzoni, K., Rehak, C., Sadlek, K., Safferstein, H., & Catalano, S. M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15212 · Cited by 24
Protein Oligomer Engineering: A New Frontier for Studying Protein Structure, Function, and Toxicity
Liu, C., & Luo, J. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202216480 · Cited by 25
Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer’s disease: analysis of Osaka mutation-knockin mice
Umeda, T., Kimura, T., Yoshida, K., Takao, K., Fujita, Y., Matsuyama, S., Sakai, A., Yamashita, M., Yamashita, Y., Ohnishi, K., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0461-5 · Cited by 26
Triptolide derivatives as potential multifunctional anti-Alzheimer agents: Synthesis and structure–activity relationship studies
Ning, C., Mo, L., Chen, X., Tu, W., Wu, J., Hou, S., & Xu, J. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.01.019 · Cited by 26
Different amyloid β42 preparations induce different cell death pathways in the model of SH-SY5Y neuroblastoma cells
Özdemir, A. Y., Hofbauerová, K., Kopecký, V., Novotný, J., & Rudajev, V. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00657-8 · Cited by 27
Versatile near-infrared fluorescent probe for in vivo detection of Aβ oligomers
Zeng, F., Yang, J., Li, X., Peng, K., Ran, C., Xu, Y., & Li, Y. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115559 · Cited by 25
Pharmacological Strategies to Improve Dendritic Spines in Alzheimer’s Disease
Ettcheto, M., Busquets, O., Cano, A. C., Sánchez‐López, E., Manzine, P. R., Espinosa-Jiménez, T., Verdaguer, E., Sureda, F. X., Olloquequi, J., Castro-Torres, R. D., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201106 · Cited by 25
Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance
Loh, D., & Reiter, R. J. (2022) · Molecules · doi:10.3390/molecules27030705 · Cited by 25
Amyloid Beta Is Internalized via Macropinocytosis, an HSPG- and Lipid Raft-Dependent and Rac1-Mediated Process
Nazere, K., Takahashi, T., Hara, N., Muguruma, K., Nakamori, M., Yamazaki, Y., Morino, H., & Maruyama, H. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.804702 · Cited by 26
Molecular dynamics simulations reveal the importance of amyloid-beta oligomer β-sheet edge conformations in membrane permeabilization
Matthes, D., & de Groot, B. L. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.103034 · Cited by 27
Single molecule experiments emphasize GM1 as a key player of the different cytotoxicity of structurally distinct Aβ1–42 oligomers
Calamai, M., Evangelisti, E., Cascella, R., Parenti, N., Cecchi, C., Stefani, M., & Pavone, F. S. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.12.009 · Cited by 27
Alzheimer's Toxic Amyloid Beta Oligomers: Unwelcome Visitors to the Na/K ATPase alpha3 Docking Station.
DiChiara, T., DiNunno, N., Clark, J. R., Bu, R. L., Cline, E. N., Rollins, M. G., Gong, Y., Brody, D. L., Sligar, S. G., Velasco, P. T., et al. (2017) · PubMed · Cited by 25
Self-citation
Rational Design of Dual-Functionalized Gd@C82 Nanoparticles to Relieve Neuronal Cytotoxicity in Alzheimer’s Disease via Inhibition of Aβ Aggregation
Yin, X., Zhou, H., Cao, T., Yang, X., Meng, F., Dai, X., Wang, Y., Li, S., Zhai, W., Yang, Z., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c08823 · Cited by 26
Influence of the Aqueous Environment on Protein Structure—A Plausible Hypothesis Concerning the Mechanism of Amyloidogenesis
Roterman, I., Banach, M., Kalinowska, B., & Konieczny, L. (2016) · Entropy · doi:10.3390/e18100351 · Cited by 24
Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model
Herline, K., Prelli, F., Mehta, P. D., MacMurray, C., Goñi, F., & Wısnıewskı, T. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0384-9 · Cited by 24
Current Strategies for Real-Time Enzyme Activation
Wang, F., Liu, Y., Du, C., & Gao, R. (2022) · Biomolecules · doi:10.3390/biom12050599 · Cited by 24
Site specific NMR characterization of abeta-40 oligomers cross seeded by abeta-42 oligomers
Chang, H., Ma, H.-I., Wu, Y., Lee, M., Yuan, E. C., Huang, S., Cheng, Y.-S., Wu, M., Tu, L., & Chan, J. C. C. (2022) · Chemical Science · doi:10.1039/d2sc01555b · Cited by 23
Amyloid-β in Alzheimer’s disease – front and centre after all?
Weglinski, C., & Jeans, A. F. (2022) · Neuronal Signaling · doi:10.1042/ns20220086 · Cited by 24
Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer’s Disease
Williams, S. M., Schulz, P., Rosenberry, T. L., Caselli, R. J., & Sierks, M. R. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161116 · Cited by 24
Fluorescent 1,4-Naphthoquinones To Visualize Diffuse and Dense-Core Amyloid Plaques in APP/PS1 Transgenic Mouse Brains
Shin, N. N., Jeon, H., Jung, Y., Baek, S., Lee, S., Yoo, H. C., Bae, G. H., Park, K., Yang, S.-H., Han, J. M., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00093 · Cited by 24
Not Oligomers but Amyloids are Cytotoxic in the Membrane‐Mediated Amyloidogenesis of Amyloid‐β Peptides
Itoh, N., Takada, E., Okubo, K., Yano, Y., Hoshino, M., Sasaki, A., Kinjo, M., & Matsuzaki, K. (2017) · ChemBioChem · doi:10.1002/cbic.201700576 · Cited by 24
Unusual Bioactive Compounds with Antioxidant Properties in Adjuvant Therapy Supporting Cognition Impairment in Age-Related Neurodegenerative Disorders
Cichoń, N., Dziedzic, A., Gorniak, L., Miller, E. D., Bijak, M., Starosta, M., & Saluk, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910707 · Cited by 24
Mechanistic Insight into the Amyloid Fibrillation Inhibition of Hen Egg White Lysozyme by Three Different Bile Acids
Jamuna, N. A., Kamalakshan, A., Dandekar, B. R., Devassy, A. M. C., Mondal, J., & Mandal, S. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c00274 · Cited by 23
An insight into the concept of neuroinflammation and neurodegeneration in Alzheimer’s disease: targeting molecular approach Nrf2, NF-κB, and CREB
Bhardwaj, S., Grewal, A. K., Singh, S., Dhankar, V., & Jindal, A. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01502-2 · Cited by 25
Remarkably Efficient Blood–Brain Barrier Crossing Polyfluorene–Chitosan Nanoparticle Selectively Tweaks Amyloid Oligomer in Cerebrospinal Fluid and Aβ1–40
Chowdhury, S. R., Mondal, S., Balakrishnan, M., Balaji, S., Trivedi, V., & Iyer, P. K. (2018) · ACS Omega · doi:10.1021/acsomega.8b00764 · Cited by 22
Interactions between BIM Protein and Beta-Amyloid May Reveal a Crucial Missing Link between Alzheimer’s Disease and Neuronal Cell Death
Malishev, R., Nandi, S., Śmiłowicz, D., Bakavayev, S., Engel, S., Bujanover, N., Gazit, R., Metzler‐Nolte, N., & Jelinek, R. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00177 · Cited by 21
Anti-inflammatory Activity of a Polypeptide Fraction From Achyranthes bidentate in Amyloid β Oligomers Induced Model of Alzheimer’s Disease
Ge, X., Wang, Y., Yu, S., Cao, X., Chen, Y., Cheng, Q., & Ding, F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716177 · Cited by 22
Aesculin offers increased resistance against oxidative stress and protective effects against Aβ-induced neurotoxicity in Caenorhabditis elegans
Wang, Y., Cheng, Q., Su, Q., Yu, X., Shen, T., Yang, X., & Jia, W. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174755 · Cited by 23
Effects of Involuntary and Voluntary Exercise in Combination with Acousto-Optic Stimulation on Adult Neurogenesis in an Alzheimer's Mouse Model
Li, W., Gao, J.-Y., Lin, S.-Y., Pan, S.-T., Xiao, B., Ma, Y.-T., Xie, K., Shen, W., Liu, Z.-T., Li, G.-Y., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02784-9 · Cited by 23
BACE-1 Inhibitors Targeting Alzheimer's Disease
Monteiro, K. L. C., Alcântara, M. G. D. S., Freire, N. M. L., Brandão, E. M., do Nascimento, V. L., Viana, L. M. D. S., de Aquino, T. M., & da Silva‐Júnior, E. F. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230612155953 · Cited by 23
Using N-Terminal Coordination of Cu(II) and Ni(II) to Isolate the Coordination Environment of Cu(I) and Cu(II) Bound to His13 and His14 in Amyloid-β(4–16)
Pushie, M. J., Stefaniak, E., Sendzik, M. R., Sokaras, D., Kröll, T., & Haas, K. L. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b01940 · Cited by 22
Oxidative DNA Damage Signalling in Neural Stem Cells in Alzheimer’s Disease
Kieroń, M., Żekanowski, C., Falk, A., & Wężyk, M. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2149812 · Cited by 22
Adult hippocampal neurogenesis: New avenues for treatment of brain disorders
Chen, L., Li, Z., Wang, W., Zhou, Y., Li, W., & Wang, Y. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102600 · Cited by 25
Tangeretin Inhibits BACE1 Activity and Attenuates Cognitive Impairments in AD Model Mice
Bao, J., Liang, Z., Gong, X., Zhao, Y., Wu, M., Liu, W., Tu, C., Wang, X., & Shu, X. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07241 · Cited by 21
Engineering a thermostable biosensor based on biomimetic mineralization HRP@Fe-MOF for Alzheimer’s disease
Miao, Y., Zhong, Q., & Ren, H. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-04367-y · Cited by 21
Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 25
Dauricine alleviates cognitive impairment in Alzheimer's disease mice induced by D-galactose and AlCl3 via the Ca2+/CaM pathway
Xue, J., Li, J.-Q., Wang, C.-C., Ma, X., Dai, H., Xu, C., & Meng, X. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116613 · Cited by 23
Nasal delivery of polymeric nanoDisc mobilizes a synergy of central and peripheral amyloid-β clearance to treat Alzheimer’s disease
Zhang, H., Chen, Y., Yu, M., Xi, Y., Han, G., Jin, Y., Wang, G.-J., Sun, X., Zhou, J., & Ding, Y. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2304213120 · Cited by 21
The Single Toxin Origin of Alzheimer’s Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention
Tolar, M., Hey, J. A., Power, A., & Abushakra, S. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052727 · Cited by 23
Indirubin Derivative 7-Bromoindirubin-3-Oxime (7Bio) Attenuates Aβ Oligomer-Induced Cognitive Impairments in Mice
Chen, L., Huang, C., Shentu, J., Wang, M., Yan, S., Fei, Z., Zhang, Z., Wang, C., Han, Y., Wang, Q., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00393 · Cited by 21
Platelet-driven formation of interface peptide nano-network biosensor enabling a non-invasive means for early detection of Alzheimer's disease
Zhang, K., Yang, Q., Fan, Z., Zhao, J., & Li, H. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111701 · Cited by 21
Enhancing α-secretase Processing for Alzheimer’s Disease—A View on SFRP1
Tang, B. L. (2020) · Brain Sciences · doi:10.3390/brainsci10020122 · Cited by 21
Exosomal Aβ-Binding Proteins Identified by “In Silico” Analysis Represent Putative Blood-Derived Biomarker Candidates for Alzheimer´s Disease
Martins, T. S., Marçalo, R., Ferreira, M., Vaz, M., Silva, R. M., Rosa, I. M., Vogelgsang, J. S., Wiltfang, J., Silva, O. A. B. D. C. E., & Henriques, A. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083933 · Cited by 21
Inhibition of Astrocytic Histamine N-Methyltransferase as a Possible Target for the Treatment of Alzheimer’s Disease
Flores‐Clemente, C., Nicolás‐Vázquez, M. I., Jiménez, E. M., & Rodríguez, M. H. (2021) · Biomolecules · doi:10.3390/biom11101408 · Cited by 21
Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model
Goñi, F., Martá-Ariza, M., Herline, K., Peyser, D. K., Boutajangout, A., Mehta, P. D., Drummond, E., Prelli, F., & Wısnıewskı, T. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0337-3 · Cited by 20
Future horizons in Alzheimer's disease research
Wısnıewskı, T., & Drummond, E. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.08.001 · Cited by 20

Authors: Viola, K. L., & Klein, W. L.
Affiliations: Northwestern University (US)
Corresponding author: Klein, William L.
ORCID: Viola, Kirsten L.
Klein, William L.
Venue: Acta Neuropathologica
Publisher: Springer Science and Business Media LLC
Published: 2015-01-22
Volume: 129
Issue: 2
Pages: 183-206
ISSN: 0001-6322 (ISSN-L)
1432-0533
DOI: 10.1007/s00401-015-1386-3
PMC: PMC4390393
OpenAlex: W2055775253
Cited by: 628
References: 198
Citations by year: 2026: 42 · 2025: 45 · 2024: 55 · 2023: 51 · 2022: 75 · 2021: 69 · 2020: 66 · 2019: 58 · 2018: 60 · 2017: 53 · 2016: 42 · 2015: 10
FWCI: 6.76
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Acta Neuropathologica (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Institute on Aging (AG045637, AG029460, R01AG022547, AG022547, R01AG029460, R21AG045637)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: amyloid-beta oligomers, Alzheimer's disease pathogenesis, protein aggregation, neurotoxicity, synaptic dysfunction, glutamate receptors, calcium overload, tau hyperphosphorylation, insulin resistance, oxidative stress, synaptic loss, cerebrospinal fluid biomarkers, diabetes comorbidity, hypercholesterolemia, Alzheimer's disease therapeutics
MeSH terms: Alzheimer Disease, Animals, Humans, Neurons, Amyloid beta-Peptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks